{"id":25590,"date":"2024-10-03T16:00:44","date_gmt":"2024-10-03T14:00:44","guid":{"rendered":"https:\/\/www.lpalaw.com\/lpa-cgr-avocats-conseille-orbimed-societe-dinvestissement-dans-le-domaine-de-la-sante-sur-un-accord-de-monetisation-de-royalties-de-50-millions-de-dollars-avec-poxel\/"},"modified":"2024-10-04T17:03:52","modified_gmt":"2024-10-04T15:03:52","slug":"lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel","status":"publish","type":"post","link":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/","title":{"rendered":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel"},"content":{"rendered":"<p>Paris, September 30th 2024<\/p>\n<h2>LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel<\/h2>\n<p>LPA-CGR avocats, BCLP and Covington &amp; Burling have advised OrbiMed, a leading healthcare investment company, on a cross-border USD 50 million financing agreement with Poxel, to monetize a portion of Poxel\u2019s future royalties and sales-based payments from the sales of Poxel\u2019s TWYMEEG\u00ae (Imeglimin) by Sumitomo Pharma in Japan, secured by two French law security trusts into which several assets (including patents, license agreements, future cash flow and receivables) are transferred.<\/p>\n<p>Managing around $17 billion in assets, OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty\/credit funds. With more than 100 professionals, the firm operates from key global hubs such as New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and more.<\/p>\n<p>Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology. TWYMEEG\u00ae, Poxel\u2019s first-in-class product that targets mitochondrial dysfunction, is marketed for the treatment of type 2 diabetes in Japan by Sumitomo Pharma. Listed on Euronext Paris, Poxel is headquartered in Lyon, and has subsidiaries in Boston and Tokyo.<\/p>\n<p>LPA-CGR avocats have assisted OrbiMed on this transaction on corporate matters, with <a href=\"https:\/\/www.lpalaw.com\/en\/team\/christian-sauer\/\" target=\"_blank\" rel=\"noopener\">Christian Sauer<\/a>, partner, and <a href=\"https:\/\/www.lpalaw.com\/en\/team\/karim-ben-khamsa\/\" target=\"_blank\" rel=\"noopener\">Karim Ben Khamsa<\/a>, associate.<\/p>\n<p>OrbiMed was also advised by BCLP (restructuring: Didier Bru\u00e8re-Dawson, partner and Marie Gicquel, counsel, IP: Pierre-Emmanuel Forg\u00e9, counsel, tax: Olivier Mesmin, partner and Thomas Poiret, senior associate) and Covington &amp; Burling in the USA.<\/p>\n<p>Dechert LLP (Paris and New York) advised Poxel: Vincent Privat, Olivia Bernardeau-Paupe, Julie Lecomte \u2013 Paris.<\/p>\n<p>To read Poxel&#8217;s press release, please <a href=\"https:\/\/d1io3yog0oux5.cloudfront.net\/_e3b64b0d99fb6e7595cac76f406c57e5\/poxelpharma\/db\/422\/4056\/pdf\/Poxel_30092024_Monetisation_FR.pdf\" target=\"_blank\" rel=\"noopener\">click here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel LPA-CGR avocats, BCLP and Covington &amp; Burling have advised OrbiMed, a leading healthcare investment company, on a cross-border USD 50 million financing agreement with Poxel, to monetize a portion of Poxel\u2019s future royalties [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[47],"tags":[1196,1197,1203,1204,1215],"class_list":["post-25590","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","tag-christian-sauer-2","tag-christian-sauer-3","tag-orbimed","tag-poxel","tag-twymeeg","cat-savoir-faire-fusions-acquisitions-droits-societes","cat-savoir-faire-sante"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats<\/title>\n<meta name=\"description\" content=\"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats\" \/>\n<meta property=\"og:description\" content=\"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\" \/>\n<meta property=\"og:site_name\" content=\"Business Lawyers | LPA Law Avocats\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-03T14:00:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-04T15:03:52+00:00\" \/>\n<meta name=\"author\" content=\"Eva Komar\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@lpalaw\" \/>\n<meta name=\"twitter:site\" content=\"@lpalaw\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eva Komar\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\"},\"author\":{\"name\":\"Eva Komar\",\"@id\":\"https:\/\/www.lpalaw.com\/#\/schema\/person\/67509c7daf80ae841b9c4df2150e8931\"},\"headline\":\"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel\",\"datePublished\":\"2024-10-03T14:00:44+00:00\",\"dateModified\":\"2024-10-04T15:03:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\"},\"wordCount\":296,\"publisher\":{\"@id\":\"https:\/\/www.lpalaw.com\/#organization\"},\"keywords\":[\"Christian Sauer\",\"Christian Sauer\",\"Orbimed\",\"Poxel\",\"TWYMEEG\"],\"articleSection\":[\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\",\"url\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\",\"name\":\"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats\",\"isPartOf\":{\"@id\":\"https:\/\/www.lpalaw.com\/#website\"},\"datePublished\":\"2024-10-03T14:00:44+00:00\",\"dateModified\":\"2024-10-04T15:03:52+00:00\",\"description\":\"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.lpalaw.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse\",\"item\":\"https:\/\/www.lpalaw.com\/actus\/communique-de-presse\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lpalaw.com\/#website\",\"url\":\"https:\/\/www.lpalaw.com\/\",\"name\":\"Avocats d\u2019affaires | LPA Law\",\"description\":\"Business Lawyers\",\"publisher\":{\"@id\":\"https:\/\/www.lpalaw.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lpalaw.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.lpalaw.com\/#organization\",\"name\":\"LPA Law\",\"url\":\"https:\/\/www.lpalaw.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.lpalaw.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.lpalaw.com\/wp-content\/uploads\/2019\/03\/lpa.png\",\"contentUrl\":\"https:\/\/www.lpalaw.com\/wp-content\/uploads\/2019\/03\/lpa.png\",\"width\":130,\"height\":101,\"caption\":\"LPA Law\"},\"image\":{\"@id\":\"https:\/\/www.lpalaw.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/lpalaw\",\"https:\/\/www.linkedin.com\/company\/lpa-cgr-avocats\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.lpalaw.com\/#\/schema\/person\/67509c7daf80ae841b9c4df2150e8931\",\"name\":\"Eva Komar\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g\",\"caption\":\"Eva Komar\"},\"url\":\"https:\/\/www.lpalaw.com\/en\/author\/eva-komar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats","description":"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/","og_locale":"en_US","og_type":"article","og_title":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats","og_description":"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement","og_url":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/","og_site_name":"Business Lawyers | LPA Law Avocats","article_published_time":"2024-10-03T14:00:44+00:00","article_modified_time":"2024-10-04T15:03:52+00:00","author":"Eva Komar","twitter_card":"summary_large_image","twitter_creator":"@lpalaw","twitter_site":"@lpalaw","twitter_misc":{"Written by":"Eva Komar","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#article","isPartOf":{"@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/"},"author":{"name":"Eva Komar","@id":"https:\/\/www.lpalaw.com\/#\/schema\/person\/67509c7daf80ae841b9c4df2150e8931"},"headline":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel","datePublished":"2024-10-03T14:00:44+00:00","dateModified":"2024-10-04T15:03:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/"},"wordCount":296,"publisher":{"@id":"https:\/\/www.lpalaw.com\/#organization"},"keywords":["Christian Sauer","Christian Sauer","Orbimed","Poxel","TWYMEEG"],"articleSection":["Communiqu\u00e9 de presse"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/","url":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/","name":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel - Business Lawyers | LPA Law Avocats","isPartOf":{"@id":"https:\/\/www.lpalaw.com\/#website"},"datePublished":"2024-10-03T14:00:44+00:00","dateModified":"2024-10-04T15:03:52+00:00","description":"Paris, September 30th 2024 LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement","breadcrumb":{"@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lpalaw.com\/en\/lpa-cgr-avocats-advises-orbimed-a-leading-healthcare-investment-company-on-usd-50-million-royalties-monetization-agreement-with-poxel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.lpalaw.com\/en\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse","item":"https:\/\/www.lpalaw.com\/actus\/communique-de-presse\/"},{"@type":"ListItem","position":3,"name":"LPA-CGR avocats advises OrbiMed, a leading healthcare investment company, on USD 50 million royalties monetization agreement with Poxel"}]},{"@type":"WebSite","@id":"https:\/\/www.lpalaw.com\/#website","url":"https:\/\/www.lpalaw.com\/","name":"Avocats d\u2019affaires | LPA Law","description":"Business Lawyers","publisher":{"@id":"https:\/\/www.lpalaw.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lpalaw.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.lpalaw.com\/#organization","name":"LPA Law","url":"https:\/\/www.lpalaw.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.lpalaw.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.lpalaw.com\/wp-content\/uploads\/2019\/03\/lpa.png","contentUrl":"https:\/\/www.lpalaw.com\/wp-content\/uploads\/2019\/03\/lpa.png","width":130,"height":101,"caption":"LPA Law"},"image":{"@id":"https:\/\/www.lpalaw.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/lpalaw","https:\/\/www.linkedin.com\/company\/lpa-cgr-avocats\/"]},{"@type":"Person","@id":"https:\/\/www.lpalaw.com\/#\/schema\/person\/67509c7daf80ae841b9c4df2150e8931","name":"Eva Komar","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6b5cbedf2f330ceeec7c7278de873c73279266dd46ef1e30a7abd97eb4cdc06e?s=96&d=mm&r=g","caption":"Eva Komar"},"url":"https:\/\/www.lpalaw.com\/en\/author\/eva-komar\/"}]}},"_links":{"self":[{"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/posts\/25590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/comments?post=25590"}],"version-history":[{"count":5,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/posts\/25590\/revisions"}],"predecessor-version":[{"id":25600,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/posts\/25590\/revisions\/25600"}],"wp:attachment":[{"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/media?parent=25590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/categories?post=25590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lpalaw.com\/en\/wp-json\/wp\/v2\/tags?post=25590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}